Solesence (SLSN) reported a revenue decline to $13 million in Q1 2026, down from $14.6 million due to shipment delays linked to on-time, in-full (OTIF) performance issues. Despite the revenue drop, the company improved its gross margin by 300 basis points to 26%, driven by enhanced labor efficiency and reduced product waste. However, net income fell to a loss of $0.8 million, compared to a profit of $0.08 million in the prior year, reflecting the costs associated with their ongoing operational transformation.
The significance of these results lies in Solesence’s strategic focus on transitioning from a traditional contract development and manufacturing organization (CDMO) to a supply-side innovation partner. Management reaffirmed a 30% gross margin floor and aims to achieve double-digit EBITDA margins by year-end, supported by operational improvements and new product launches under the Chromalum and WHSPR technology platforms. The company’s $47 million in shipped and open orders indicates sustained demand amid its restructuring efforts.
For market professionals, the key takeaway is that while Solesence faces short-term challenges, its commitment to operational excellence and innovation positions it for potential long-term growth and recovery in profitability as it executes its Transform and Transcend initiative.
Source: fool.com